Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani(The University of Texas MD Anderson Cancer Center), Thomas A. D’Amico(Cancer Institute (WIA)), Khaldoun Almhanna(University of South Florida), David J. Bentrem, Joseph Chao(City Of Hope National Medical Center), Prajnan Das(The University of Texas MD Anderson Cancer Center), Crystal S. Denlinger(Fox Chase Cancer Center), Paul T. Fanta(University of California San Diego), Farhood Farjah(Seattle Cancer Care Alliance), Charles S. Fuchs(Dana-Farber Brigham Cancer Center), Hans Gerdes(Memorial Sloan Kettering Cancer Center), Michael K. Gibson(Case Western Reserve University), Robert E. Glasgow(University of Utah), James A. Hayman(University of Michigan), Steven N. Hochwald(Roswell Park Comprehensive Cancer Center), Wayne L. Hofstetter(The University of Texas MD Anderson Cancer Center), David H. Ilson(Memorial Sloan Kettering Cancer Center), Dawn E. Jaroszewski(Mayo Clinic in Arizona), Kimberly L. Johung(Yale Cancer Center), Rajesh N. Keswani, Lawrence Kleinberg(Johns Hopkins University), W. Michael Korn(University of California, San Francisco), Stephen Leong(University of Colorado Cancer Center), Catherine Linn(Vanderbilt University), A. Craig Lockhart(Washington University in St. Louis), Quan P. Ly(University of Nebraska Medical Center), Mary F. Mulcahy, Mark B. Orringer(University of Michigan), Kyle A. Perry(The Ohio State University), George A. Poultsides(Stanford University), Walter J. Scott(Fox Chase Cancer Center), Vivian E. Strong(Memorial Sloan Kettering Cancer Center), M. Kay Washington(Vanderbilt University), Benny Weksler(University of Tennessee Health Science Center), Christopher G. Willett(Cancer Institute (WIA)), Cameron D. Wright(Harvard University Press), Debra Zelman(Dream Foundation), Nicole R. McMillian, Hema Sundar
Journal of the National Comprehensive Cancer Network
October 1, 2016
10.6004/jnccn.2016.0137
Cited by 955Open Access
Full Text

Abstract

Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.

Related Papers

No related papers found

Powered by citation graph analysis